Patel Sandip I — SEC Form 4 filings
SEC reporting owner CIK 1843601. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-16 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | Director | 3 | — | — | 9 |
| Peak Bio, Inc. (PKBO) | Director | 1 | — | — | 7 |
| AtlasClear Holdings, Inc. (ATCH) | CFO and General Counsel, Director | 2 | — | — | 4 |
| Quantum FinTech Acquisition Corp (QFTA) | Director | 1 | — | — | 1 |
Form 4 filings — Patel Sandip I
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | AtlasClear Holdings, Inc. (ATCH) | Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 731,030 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 247,462 (derivative) · Purchase (P): 247,462 (derivative) @ $0.40 · Purchase (P): 154,664 (derivative) · Purchase (P): 154,664 (derivative) @ $0.40 | EDGAR |
| 2025-04-29 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 | EDGAR |
| 2025-03-24 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Peak Bio, Inc. (PKBO) | Conversion (C): 763,316 · Disposition to issuer (D): 763,316 · Disposition to issuer (D): 67,735 · Disposition to issuer (D): 68,891 · Disposition to issuer (D): 47,364 · Conversion (C) · +1 more | EDGAR |
| 2024-04-16 | 4 | AtlasClear Holdings, Inc. (ATCH) | Other (J): 201,860 · Other (J): 354,088 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Quantum FinTech Acquisition Corp (QFTA) | Disposition to issuer (D): 41,334 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1843601 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →